• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Infertility treatments not associated with increased short-term cancer risk

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
August 16, 2015
in Obstetrics, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Compared to the general population, women who underwent assisted reproductive technologies (ART) treatments were not at increased risk for developing cancer after approximately 5 years of follow-up.

2. ART treatment was not associated with an increased risk of uterine, ovarian or endocrine cancers and was associated with a reduced risk of breast cancer.

Evidence Rating Level: 2 (Good)

Study Rundown: Use of ART treatments, such as in vitro fertilization, intrauterine insemination and intracytoplasmic sperm injection has steadily grown in the United States over the past two decades. From 2000 to 2012, the number of ART cycles grew more than 75% from 99 629 to 176 247 cycles annually. Certain demographic factors are more common in women undergoing ART treatments and are also risk factors for certain cancers. These include low parity, older age at first birth and a lower incidence of breastfeeding. Moreover, ART can include hormonal therapies which concern some for an increased risk of hormone-sensitive cancers. However, only small observational studies have been conducted on the topic. In 2004, The Society for Assisted Reproductive Technology (SART) made public the SART Clinical Outcome Reporting System (CORS) database, which contains comprehensive data from more than 90 percent of clinics providing ART treatments in the U.S. Researchers in the present study used SART CORS data from large infertility practices in New York, Texas, and Illinois, along with State Cancer Registries, to compare the incidence of cancers among women treated with ART to the incidence of cancers in the general population.

After an average of nearly 5 years of follow-up, the incidence of cancer diagnoses among women who underwent ART treatments did not differ from age-specific general population incidence. Strengths included large, nationally representative population. Limitations included observational study and short follow-up time with regard to the outcome of interest, particularly since cancer diagnoses in reproductive-age women is relatively low. Future investigations might prospectively compare the incidence of new cancer diagnoses in women after ART treatments and in women with infertility who did not undergo ART treatments across a longer duration of follow-up.

Click to read the study in Fertility and Sterility

RELATED REPORTS

Similar perinatal outcomes observed amongst conception via natural and assisted reproductive means

Double embryo transfer may be associated with neonatal risks

Early differences in growth and adiposity among offspring conceived using assisted reproductive technology attenuated by late adolescence

Relevant Reading: Causes of Infertility as Predictors of Subsequent Cancer Risk

In-Depth [prospective cohort study]: Using the SART database, researchers collected information on 113 226 women in New York, Texas, and Illinois who underwent ART treatment cycles from 2004-2009. Cancer diagnoses were detected in state cancer registries with mean follow-up of 4.87 years. The main outcome was diagnosis of cancer. Cancer incidence in women who underwent ART treatments was compared to state and age-matched cancer incidence in the general population to generate standardized incidence ratios (SIR).

Among 53 782 women undergoing ART treatments, 450 developed cancer over the follow-up period. Compared to state and age-matched omen who underwent ART had a lower risk for all cancers (SIR: 0.78, 95% CI: 0.73-0.83), breast cancer (SIR: 0.83, 95% CI: 0.75, 0.91) and all female genital cancers compared to state and age-matched cancer incidence estimates in the general population. Results were not modulated by parity, number of cycles, or cumulative follicle-stimulating hormone (FSH) dosage.

Image: CC/Wikimedia Commons/ScienceGenetics

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: assisted reproduction
Previous Post

Psychiatric conditions less likely to be granted physician-assisted suicide

Next Post

Effectiveness of progesterone for prevention of preterm birth varies with BMI

RelatedReports

Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia
Obstetrics

Similar perinatal outcomes observed amongst conception via natural and assisted reproductive means

April 19, 2023
Assisted conception not associated with increased pediatric cancer risk
Endocrinology

Double embryo transfer may be associated with neonatal risks

December 19, 2022
The PIP trial: no difference in live birth rate observed for patients undergoing endometrial scratching
Obstetrics

Early differences in growth and adiposity among offspring conceived using assisted reproductive technology attenuated by late adolescence

August 4, 2022
Infertility treatments not associated with increased short-term cancer risk
Obstetrics

Infertility linked to higher birth defect risk

April 10, 2016
Next Post
Effectiveness of progesterone for prevention of preterm birth varies with BMI

Effectiveness of progesterone for prevention of preterm birth varies with BMI

2 Minute Medicine Rewind November 23 – November 30, 2014

Vaccine protects macaques from the West African Ebola virus [PreClinical]

Mandatory eye protection may reduce field hockey injuries

Mandatory eye protection may reduce field hockey injuries

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis
  • #VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline
  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.